Genematrix gets top patent technology award

Published: 2007-07-26 06:56:00

Updated: 2007-07-26 06:56:00

Genematrix, a local biopharmaceutical company, received the top prize of this year's Patent Technology Award, selected by the Korean Intellectual Property Office, for recognition of developing a new method - restriction fragment mass polymorphism (RFMP) analysis for genotyping Hepatits C virus (H...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK